Literature DB >> 16693608

Spiramycin for Toxoplasmosis.

J V Cassady, J W Bahler, M V Hinken.   

Abstract

Entities:  

Year:  1963        PMID: 16693608      PMCID: PMC1316644     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


× No keyword cloud information.
  7 in total

1.  Treatment of toxoplasmosis uveitis.

Authors:  R V FAJARDO; F P FURGIUELE; I H LEOPOLD
Journal:  Arch Ophthalmol       Date:  1962-06

2.  The treatment of ocular toxoplasmosis with spiramycin.

Authors:  J B CHODOS; H E HABEGGER-CHODOS
Journal:  Arch Ophthalmol       Date:  1961-03

3.  [Tissue fixation of spiramycin in guinea pig; comparison with other antibiotics].

Authors:  J PELLERAT; M A MAILLARD
Journal:  C R Hebd Seances Acad Sci       Date:  1958-09-22

4.  Spiramycin; clinical and laboratory studies.

Authors:  D G HUDSON; G M YOSHIHARA; W M KIRBY
Journal:  AMA Arch Intern Med       Date:  1956-01

5.  [Not Available].

Authors:  Y CHABBERT
Journal:  Ann Inst Pasteur (Paris)       Date:  1955-10

6.  [Spiramycin therapy of experimental toxoplasmosis in mice].

Authors:  J P GARIN; D E EYLES
Journal:  Presse Med       Date:  1958-05-28       Impact factor: 1.228

7.  The acute oral toxicity of spiramycin.

Authors:  E M BOYD
Journal:  Can J Biochem Physiol       Date:  1958-01
  7 in total
  1 in total

1.  Development and characterization of in situ oral gel of spiramycin.

Authors:  Avinash Sharma; Jyoti Sharma; Rupinder Kaur; Vinay Saini
Journal:  Biomed Res Int       Date:  2014-06-24       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.